Robert Hamilton Pierce Insider Profile
4 Followers
Robert Hamilton Pierce, Chief R&D Officer at Faeth Therapeutics, holds 21.00K shares in Faeth Therapeutics (Ticker: FTH), holds 0.00 shares in OncoSec Medical (Ticker: ONCSQ).
Robert Hamilton Pierce's Trading History
You May Also Like
Robert Hamilton Pierce insider profile FAQ
What is the percentage of profitable transactions made by Robert Hamilton Pierce?
The percentage of profitable transactions made by Robert Hamilton Pierce is 100%.
What is the average return per transaction made by Robert Hamilton Pierce?
The average return per transaction made by Robert Hamilton Pierce is 71.40%.
What stocks does Robert Hamilton Pierce hold?
Robert Hamilton Pierce holds: FTH, ONCSQ stocks.
What was Robert Hamilton Pierce's most profitable transaction?
Robert Hamilton Pierce’s most profitable transaction was an Informative Sell of FTH stock on August 12, 2021. The return on the trade was 72.00%.
What is Robert Hamilton Pierce's role in Faeth Therapeutics?
Robert Hamilton Pierce's role in Faeth Therapeutics is Chief R&D Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
